Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The human papillomavirus (HPV) vaccine market was valued at USD 5.83 Billion in 2025 driven by the rising incidence of HPV-related disease and technological advancements in vaccine technology across the 8 major markets. It is expected to grow at a CAGR of 11.60% during the forecast period 2026-2035 and attain a market value of USD 17.47 Billion by 2035.
Base Year
Historical Period
Forecast Period
In the United States, around 47,984 new cases of cancer related to human papillomavirus (HPV) are identified annually, with 26,280 cases in females and 21,704 in males. This indicates the increasing prevalence of HPV-related diseases, which is expected to fuel the market demand.
In September 2024, Merck announced positive top-line results from a Phase 3 trial evaluating the efficacy and safety of the 9-valent Human Papillomavirus (HPV) vaccine GARDASIL®9 in Japanese males aged 16 to 26. The growth in such clinical trials is a significant market trend.
The FDA granted Breakthrough Therapy Designation in September 2023 for INO -3107, which targets recurrent respiratory papillomatosis, a rare disease caused by HPV-6 and/or HPV-11. The robust regulatory support from health authorities like the FDA is likely to elevate the market value.
The report presents a detailed analysis of the following key players in the global human papillomavirus (HPV) vaccine market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The comprehensive report looks into the macro and micro aspects of the market. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2025, the global human papillomavirus (HPV) vaccine market attained a value of nearly USD 5.83 Billion.
The market is assessed to grow at a CAGR of 11.60% between 2026 and 2035.
The market is estimated to witness healthy growth in the forecast period of 2026-2035 to reach almost USD 17.47 Billion by 2035.
The major market drivers are the growing awareness regarding human papillomavirus, the rising incidences of HPV-associated cancers, the increasing healthcare facilities.
The key market trends guiding the growth of the market include the introduction of various government initiatives to boost HPV vaccination, the growing incidences of HPV-related malignancies, and developing healthcare infrastructure.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The various types of human papillomavirus virus (HPV) vaccine in the market are bivalent and polyvalent.
The different distribution channel of human papillomavirus (HPV) vaccine include hospital and retail pharmacies and government suppliers, among others.
The significant indications of human papillomavirus (HPV) vaccine in the market are genital warts and HPV associated cancer.
The major diseases of human papillomavirus (HPV) vaccine, include systemic human papillomavirus vaccine and localised human papillomavirus vaccine.
The major players in the market are Merck & Co., Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Serum Institute of India Pvt. Ltd., and Bavarian Nordic A/S, among others.
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124